Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2016 | 1 |
2018 | 1 |
2021 | 1 |
2024 | 1 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Proceedings of the 3rd IPLeiria's International Health Congress : Leiria, Portugal. 6-7 May 2016.
BMC Health Serv Res. 2016 Jul 6;16 Suppl 3(Suppl 3):200. doi: 10.1186/s12913-016-1423-5.
BMC Health Serv Res. 2016.
PMID: 27409075
Free PMC article.
Gutierrez, Gemma M. Milanes, Mercedes G. Reina, Ana G. Villanueva, Ana S. Pinero, Isabel R. ...Rodriguez-De-Vera O15 Risk of malnutrition in the elderly of Braganca Alexandra Parente, M Augusta Mata, Ana M Pereira, Adilia Fernandes, Manuel Bras …
Gutierrez, Gemma M. Milanes, Mercedes G. Reina, Ana G. Villanueva, Ana S. Pinero, Isabel R. ...Rodriguez-De-Vera O15 Ri …
Proceedings of Reanimation 2021, the French Intensive Care Society International Congress.
[No authors listed]
[No authors listed]
Ann Intensive Care. 2021 Jun 29;11(Suppl 1):97. doi: 10.1186/s13613-021-00862-0.
Ann Intensive Care. 2021.
PMID: 34185186
Free PMC article.
No abstract available.
Item in Clipboard
Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021.
GBD 2021 Demographics Collaborators.
GBD 2021 Demographics Collaborators.
Lancet. 2024 Mar 8:S0140-6736(24)00476-8. doi: 10.1016/S0140-6736(24)00476-8. Online ahead of print.
Lancet. 2024.
PMID: 38484753
Free article.
Item in Clipboard
Spironolactone Versus Clonidine as a Fourth-Drug Therapy for Resistant Hypertension: The ReHOT Randomized Study (Resistant Hypertension Optimal Treatment).
Krieger EM, Drager LF, Giorgi DMA, Pereira AC, Barreto-Filho JAS, Nogueira AR, Mill JG, Lotufo PA, Amodeo C, Batista MC, Bodanese LC, Carvalho ACC, Castro I, Chaves H, Costa EAS, Feitosa GS, Franco RJS, Fuchs FD, Guimarães AC, Jardim PC, Machado CA, Magalhães ME, Mion D Jr, Nascimento RM, Nobre F, Nóbrega AC, Ribeiro ALP, Rodrigues-Sobrinho CR, Sanjuliani AF, Teixeira MDCB, Krieger JE; ReHOT Investigators.
Krieger EM, et al.
Hypertension. 2018 Apr;71(4):681-690. doi: 10.1161/HYPERTENSIONAHA.117.10662. Epub 2018 Feb 20.
Hypertension. 2018.
PMID: 29463627
Clinical Trial.
The primary end point was BP control during office (<140/90 mm Hg) and 24-h ambulatory (<130/80 mm Hg) BP monitoring. Secondary end points included BP control from each method and absolute BP reduction. ...Secondary end point analysis showed similar office BP (33.3% …
The primary end point was BP control during office (<140/90 mm Hg) and 24-h ambulatory (<130/80 mm Hg) BP monitoring. Secondary …
Item in Clipboard
Cite
Cite